Impact of IL-2 on Treatment Tolerance in Patients With High-Risk Neuroblastoma Treated With Dinutuximab Beta-Based Immunotherapy
Cicek, Filiz, Troschke-Meurer, Sascha, Ceylan, Kiraz, Jahns, Luciana J, Zumpe, Maxi, Siebert, Nikolai, Ehlert, Karoline, Lode, Holger N
Published in Frontiers in pediatrics (16.12.2020)
Published in Frontiers in pediatrics (16.12.2020)
Get full text
Journal Article
Inflammatory response and treatment tolerance of long-term infusion of the anti-GD 2 antibody ch14.18/CHO in combination with interleukin-2 in patients with high-risk neuroblastoma
Ceylan, Kiraz, Jahns, Luciana J, Lode, Bjoern N, Ehlert, Karoline, Kietz, Silke, Troschke-Meurer, Sascha, Siebert, Nikolai, Lode, Holger N
Published in Pediatric blood & cancer (01.06.2018)
Published in Pediatric blood & cancer (01.06.2018)
Get full text
Journal Article
Inflammatory response and treatment tolerance of long‐term infusion of the anti‐GD2 antibody ch14.18/CHO in combination with interleukin‐2 in patients with high‐risk neuroblastoma
Ceylan, Kiraz, Jahns, Luciana J., Lode, Bjoern N., Ehlert, Karoline, Kietz, Silke, Troschke‐Meurer, Sascha, Siebert, Nikolai, Lode, Holger N.
Published in Pediatric blood & cancer (01.06.2018)
Published in Pediatric blood & cancer (01.06.2018)
Get full text
Journal Article